Skip to content

Clinical trials

Phase 2 Lymphoma, Follicular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 2 Country / region: China Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20151
20171
20183
20195
20204
20214
20221
20232
20247
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting15
Unknown status9
Completed6
Not yet recruiting6
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University4
The First Affiliated Hospital of Xiamen University4
Institute of Hematology & Blood Diseases Hospital, China3
Ruijin Hospital3
BeiGene2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Chinese PLA General Hospital2
AstraZeneca1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular40
Lymphoma, B-Cell, Marginal Zone6
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, B-Cell4
Lymphoma, Mantle-Cell4
Recurrence4
Lymphoma3
Lymphoma, Non-Hodgkin3
Arthritis, Rheumatoid1
Bronchopulmonary Dysplasia1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.